response

JA Mining Expands Renewable Mining Infrastructure in North America Post Completion of Independent Security Audit

DENVER, CO, July 16, 2025 (GLOBE NEWSWIRE) -- In response to rising demand for sustainable and secure digital asset participation,…

4 months ago

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

5 months ago

Heartwarming Global Response to Player Registration for Inaugural Canada Super 60 League

Thursday 17 April, 2025 Ontario, Canada – April 1, 2025 The Canada Super 60 Ten Over Format League has gained…

5 months ago

GW Instek Unveils Full Smart Measurement Portfolio to Accelerate Next-Gen Industrial Testing

TAIPEI, July 8, 2025 /PRNewswire/ -- In response to the global surge in industrial automation and smart manufacturing, precision data…

5 months ago

Marathon Nextgen Realty Raises Rs. 900 Crore Through Qualified Institutions Placement

Overwhelming Response from Premier Domestic and International Institutional Investors Validates Company's Growth Strategy MUMBAI, India, July 4, 2025 /PRNewswire/ --…

5 months ago

Big Bang Boom Solutions Accelerates Deployment of the Indigenous Vajra Sentinel System to the Indian Air Force in Response to Operation Sindoor

Big Bang Boom Solutions (BBBS) announced the successful delivery of the first lot of its Vajra Sentinel Systems, a next-generation…

5 months ago

New Glassnode Report: How Bybit’s Response to the Lazarus Hack Became Crypto’s Defining Stress Test

DUBAI, UAE, July 1, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has been featured in a…

5 months ago

Vehere Appoints Gulf Software Distribution to Accelerate Market Growth Across the Region

DUBAI, UAE, July 1, 2025 /PRNewswire/ -- Vehere, a new-age cyber defense software company, has engaged Gulf Software Distribution (GSD),…

5 months ago

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

5 months ago

Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…

5 months ago